ELMD Stock Analysis: Buy, Sell, or Hold?
ELMD - Electromed, Inc.
$29.87
1.17 (4.08%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
8d
Get Alerted When ELMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ELMD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELMD shows positive signals but monitor for confirmation. Market pricing in 3.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ELMD shows positive signals but monitor for confirmation. Market pricing in 3.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$61.11
Based on 13.9% avg growth
INTRINSIC VALUE TODAY
$37.95
21.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELMD is currently trading at $29.87, which is considered extended relative to its 30-day fair value range of $27.83 to $29.08. The stock's valuation (Forward PE: 23.2) is in line with its historical norms (25.3). Remarkably, the market is currently pricing in an annual earnings decline of 3.0% over the next few years. This pessimistic expectation contrasts with the company's recent 56.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ELMD is in a strong uptrend. The price is approaching resistance at $29.87. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: ELMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.00 (+20.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELMD is in a strong uptrend. The price is approaching resistance at $29.87. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: ELMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.00 (+20.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$27.83 -
$29.08
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 20.5% below Wall St target ($36.00)
Fair Price Analysis
30-Day Fair Range
$27.83 -
$29.08
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$1.87
(6.3%)
Support & Resistance Levels
Support Level
$27.20
Resistance Level
$29.87
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
23.16
Wall Street Target
$36.00
(+20.5%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
56.3%
Profit Margin
12.4%
Valuation Discount vs History
-3.0% cheaper
PE vs Historical
23.2 vs 25.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.0%
(market-implied from PE analysis)
1-Year Target
$28.97
(-3%)
2-Year Target
$28.10
(-6%)
3-Year Target
$27.26
(-9%)
3-Yr Target (if PE normalizes)
(PE: 23→25)
$29.79
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.2, Growth: 23.7%)
$56.59
(+90%)
Base:
(SPY PE: 22.3, Growth: 23.7%)
$54.50
(+83%)
Bear:
(PE: 19.0, Growth: 23.7%)
$46.33
(+55%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 30.95 | Current EPS (TTM): $0.94
Bull Case
$43.91
(+47%)
Analyst growth 37.2%, PE expands to 34.0
Base Case
$39.92
(+34%)
Market implied 37.2%, PE stable at 31.0
Bear Case
$19.78
(-34%)
Severe decline -20.0%, PE contracts to 26.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.2 to 25.3
Stabilization Target:
$32.64
(+9.3%)
PE Expansion Potential:
+9.3%
Last updated: January 31, 2026 9:36 PM ET
Data refreshes hourly during market hours. Next update: 10:36 PM
Data refreshes hourly during market hours. Next update: 10:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELMD showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced ELMD Option Strategies
Professional options setups generated by AI based on today's ELMD price and gamma walls.
